313 related articles for article (PubMed ID: 15148321)
1. Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling.
Mochizuki T; Miyazaki H; Hara T; Furuya T; Imamura T; Watabe T; Miyazono K
J Biol Chem; 2004 Jul; 279(30):31568-74. PubMed ID: 15148321
[TBL] [Abstract][Full Text] [Related]
2. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
3. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
Hariharan R; Pillai MR
Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
[TBL] [Abstract][Full Text] [Related]
4. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
5. Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors.
Souchelnytskyi S; Nakayama T; Nakao A; Morén A; Heldin CH; Christian JL; ten Dijke P
J Biol Chem; 1998 Sep; 273(39):25364-70. PubMed ID: 9738003
[TBL] [Abstract][Full Text] [Related]
6. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.
Imoto S; Sugiyama K; Sekine Y; Matsuda T
FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation.
Pulaski L; Landström M; Heldin CH; Souchelnytskyi S
J Biol Chem; 2001 Apr; 276(17):14344-9. PubMed ID: 11278814
[TBL] [Abstract][Full Text] [Related]
8. Endogenous patterns of TGFbeta superfamily signaling during early Xenopus development.
Faure S; Lee MA; Keller T; ten Dijke P; Whitman M
Development; 2000 Jul; 127(13):2917-31. PubMed ID: 10851136
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
10. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
[TBL] [Abstract][Full Text] [Related]
11. SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1.
Raju GP; Dimova N; Klein PS; Huang HC
J Biol Chem; 2003 Jan; 278(1):428-37. PubMed ID: 12393873
[TBL] [Abstract][Full Text] [Related]
12. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
Pardali K; Kowanetz M; Heldin CH; Moustakas A
J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
[TBL] [Abstract][Full Text] [Related]
13. Dissection of inhibitory Smad proteins: both N- and C-terminal domains are necessary for full activities of Xenopus Smad6 and Smad7.
Nakayama T; Berg LK; Christian JL
Mech Dev; 2001 Feb; 100(2):251-62. PubMed ID: 11165482
[TBL] [Abstract][Full Text] [Related]
14. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3.
Imoto S; Sugiyama K; Muromoto R; Sato N; Yamamoto T; Matsuda T
J Biol Chem; 2003 Sep; 278(36):34253-8. PubMed ID: 12815042
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for inhibitory effects of Smad7 on TGF-β family signaling.
Murayama K; Kato-Murayama M; Itoh Y; Miyazono K; Miyazawa K; Shirouzu M
J Struct Biol; 2020 Dec; 212(3):107661. PubMed ID: 33166654
[TBL] [Abstract][Full Text] [Related]
16. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.
Zhu H; Kavsak P; Abdollah S; Wrana JL; Thomsen GH
Nature; 1999 Aug; 400(6745):687-93. PubMed ID: 10458166
[TBL] [Abstract][Full Text] [Related]
17. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.
Ebisawa T; Fukuchi M; Murakami G; Chiba T; Tanaka K; Imamura T; Miyazono K
J Biol Chem; 2001 Apr; 276(16):12477-80. PubMed ID: 11278251
[TBL] [Abstract][Full Text] [Related]
18. STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling.
Datta PK; Moses HL
Mol Cell Biol; 2000 May; 20(9):3157-67. PubMed ID: 10757800
[TBL] [Abstract][Full Text] [Related]
19. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads.
Murakami G; Watabe T; Takaoka K; Miyazono K; Imamura T
Mol Biol Cell; 2003 Jul; 14(7):2809-17. PubMed ID: 12857866
[TBL] [Abstract][Full Text] [Related]
20. Xenopus Smad7 inhibits both the activin and BMP pathways and acts as a neural inducer.
Casellas R; Brivanlou AH
Dev Biol; 1998 Jun; 198(1):1-12. PubMed ID: 9640328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]